How do you attract young talent to nuclear medicine? Ask Ken Herrmann and Valentina Ambrosini

Nuclear medicine is finally having its moment. Radiopharmaceuticals are poised to bring about a sea change in the treatment of cancer – though to make sure innovation in the space remains at the cutting edge, having the right talent is arguably the single most important aspect.

 

It was this topic that led Ken Herrmann and Valentina Ambrosini, from Essen University Hospital and the University of Bologna respectively, to co-author an article for the European Journal of Nuclear Medicine and Molecular Imaging. This, in turn, caught the attention of our Senior Oncology R&D Consultant, Matthew Palmer.

 

Matt invited Ken and Valentina to speak about their findings and their own insights on this topic on the Venari Podcast. So, what do the co-authors think about addressing the generation gap in nuclear medicine, and what are the implications of their research?